Trial Profile
Clinical Trials Insight: 700046375
Status:
Not stated
Phase of Trial:
Phase I/II
Latest Information Update: 13 Jul 2009
Price :
$35
*
At a glance
- Drugs M3TK (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 29 Jun 2009 New trial record.